Tuesday, 02 January 2024 12:17 GMT

Bausch + Lomb Corporation


(MENAFN- Baystreet) 10:16 AM EST - Bausch + Lomb Corporation: Today announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the Bi-Blade+ advanced dual-port vitrectomy cutter and the Adaptive Fluidics advanced update on the Stellaris Elite® Vision Enhancement System. Bausch + Lomb Corporation shares T are trading up $0.95 at $23.10.

MENAFN08042026000212011056ID1110959308



Baystreet.ca

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search